Harvard Apparatus Regenerative Technology, Inc. Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
Harvard Apparatus Regenerative Technology, Inc. (HRGN) reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations of $3.16 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations · last filed 2024-11-13
- Harvard Apparatus Regenerative Technology, Inc. cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect disposal group including discontinued operations for the quarter ending 2024-03-31 was -$160.00K, a 107.89% decline year-over-year.
- Harvard Apparatus Regenerative Technology, Inc. cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect disposal group including discontinued operations for the quarter ending 2023-03-31 was $2.03M.
| Period end | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations 3 month | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations 6 month | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations 9 month |
|---|---|---|---|
| 2024-09-30 | $3.16M 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | -$293.00K 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | -$160.00K 10-Q · filed 2024-05-13 | ||
| 2023-09-30 | -$972.00K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $899.00K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $2.03M 10-Q · filed 2024-05-13 |